Implementation of ACT Through Facebook for Teenagers With Asthma
Launched by MASSACHUSETTS GENERAL HOSPITAL · Aug 28, 2012
Trial Information
Current as of April 25, 2025
Completed
Keywords
ClinConnect Summary
The investigators propose to administer the Asthma Control Test (ACT), a clinically validated and reliable measure of asthma control, to a pediatric pulmonary patient population, using novel channels to improve usage of the tool and health outcomes. The investigators will administer ACT to patients using Facebook to monitor asthma control and notify clinicians when there is deterioration of control.
The goal is to improve health outcomes in patients with asthma by measuring adherence to the use of monitoring tool, follow-up visits to their specialist, and hospitalization/Emergency Departme...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Teenagers age 14-17 years inclusive.
- • Diagnosis of asthma by a PCP or a specialist at a Partners affiliated hospital/health center.
- • Access to computer with internet.
- • Active email account
- • Fluency in English (spoken and written)
- • Be on controller medications (such as: inhaled corticosteroids, cromolyn sodium and nedocromil sodium, long-acting beta-agonists (LABAs), and methylxanthines) to control asthma and prevent symptoms from developing.
- • Have an active account on Facebook
- Exclusion Criteria:
- • Disability or co-morbidity precluding regular access to the internet.
- • Cognitive impairment.
About Massachusetts General Hospital
Massachusetts General Hospital (MGH) is a leading academic medical center located in Boston, Massachusetts, renowned for its commitment to advancing medical research and patient care. As a prominent teaching hospital affiliated with Harvard Medical School, MGH plays a pivotal role in clinical trials across a wide range of disciplines, including cardiology, oncology, neurology, and more. The institution is dedicated to fostering innovative research that translates into effective therapies and improved health outcomes. MGH's Clinical Trials Office provides comprehensive support to facilitate the design, implementation, and management of clinical studies, ensuring adherence to the highest ethical standards and regulatory compliance. With a focus on collaboration and patient-centered care, MGH strives to enhance medical knowledge and contribute to the future of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Boston, Massachusetts, United States
Patients applied
Trial Officials
Kamal Jethwani, MD, MPH
Principal Investigator
Partners Healthcare, Center for Connected Health
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials